Pharmacy willingness to partner with office-based opioid dependence treatment providers in conducting random buprenorphine pill counts

American Journal on Addictions

Volumn 19, Issue 2, 2010, Pages 195-196

  Lofwall, Michelle R ^a,b   Wunsch, Martha J ^a,b   Walsh, Sharon L ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CLOZAPINE; OPIATE;

ARTICLE; DRUG USE; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; MEDICAL DOCUMENTATION; MEDICAL PRACTICE; OPIATE ADDICTION; PATIENT SAFETY; PHARMACY; PHYSICIAN; PILL; PRESCRIPTION;

ATTITUDE OF HEALTH PERSONNEL; BUPRENORPHINE; COMMUNITY PHARMACY SERVICES; DIRECTLY OBSERVED THERAPY; HUMANS; OPIOID-RELATED DISORDERS;

EID: 77149171166     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2009.00026.x     Document Type: Article

References (4)

1. McLellan AT, Lewis DC, O'Brien CP, et al. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA. 2000 284 : 1689 1695.
2. Cicero TJ, Surratt HL, Inciardi J. Use and misuse of buprenorphine in the management of opioid addiction. J Opioid Manag. 2007 3 : 302 308.
3. Lawrinson P, Roche A, Terao H, et al. Dispensing opioid substitution treatment: Practices, attitudes and intentions of community-based pharmacists. Drug Alcohol Rev. 2008 27 : 47 53.
4. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008 300 : 2613 2620.